Lexicon Pharmaceuticals
Home
Contact Us
Site Map
About Us
About Us Home
Management Team
Board of Directors
Development Team
Locations
Contact Us
History
Pipeline
Drug Pipeline Home
Our Goal
Therapeutic Areas
Drug Development Team
Clinical Trials
Publications
Discovery
Discovery Home
Discovery Process
Technology
Genome5000
Medicinal Chemistry
Biotherapeutics
Patents
Academic Access
Technology Licensing
Alliances
Alliances Home
Current Alliances
Technology Licensing
Careers
Careers Home
Opportunities
Our Culture
Benefits
Community Involvement
The Woodlands
Princeton
Awards and Recognition
News
News Home
Media Inquiries
Investors
Investors Home
Media
Events
Stock Quote
SEC Filings
Annual Reports
Corporate Governance
Request Information
News Home
Media Inquiries
Subscribe
Press Releases
Filter
Display #
5
10
15
20
25
30
50
100
All
04/22/2003
Lexicon Genetics Licenses Patented Gene Targeting Technology to Aventis Pharmaceuticals
04/21/2003
Lexicon Genetics Announces Webcast of Presentation at the CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference
04/17/2003
Lexicon Genetics to Hold First Quarter 2003 Financial Results Webcast And Conference Call
03/25/2003
Lexicon Genetics Appoints Alan S. Nies, M.D. Chairman of the Medical Advisory Board
03/19/2003
Lexicon Genetics Extends OmniBank(R) Universal Agreement With Boehringer Ingelheim Pharmaceuticals Inc.
02/25/2003
Lexicon Genetics Discovers Novel Target for the Development of Treatments for Osteoporosis
02/21/2003
Lexicon Genetics Announces Webcast of Presentation at the BIO CEO & Investor Conference 2003
02/19/2003
Lexicon Genetics Reports 2002 Fourth Quarter and Full Year Financial Results; Revenues Increased 15% in 2002
01/30/2003
Lexicon Genetics to Hold Fourth Quarter and Year End 2002 Financial Results Webcast and Conference Call
01/08/2003
Lexicon Genetics Extends OmniBank(R) Universal Agreement With Johnson & Johnson Pharmaceutical Research & Development, L.L.C
«
Start
Prev
11
12
13
14
15
16
17
18
19
20
Next
End
»
Page 20 of 32